Literature DB >> 17208285

Delay aversion: effects of 7-OH-DPAT, 5-HT1A/1B-receptor stimulation and D-cycloserine.

Filip S van den Bergh1, Emilie Bloemarts, Lucianne Groenink, Berend Olivier, Ronald S Oosting.   

Abstract

Impulsive individuals often display an aversion to waiting for rewards. Delay aversion can be quantified in rats in a delayed reward task, in which animals choose between an immediately available, small reward, and a large reward available after a delay. In previous research conducted at our laboratory and in literature, positive correlations between delay aversion and aggression, substance abuse and persistence during extinction of conditioned responses were found. The correlations suggest a possible shared pharmacology. Therefore, we tested drugs with known effects on these behaviors for possible effects on delay aversion: the dopamine D(3)-receptor agonist 7-OH-DPAT, the 5-HT(1A)-receptor agonist flesinoxan, the 5HT(1A/1B)-receptor agonist eltoprazine, and the NMDA-receptor agonist d-cycloserine. The results show that 7-OH-DPAT slightly decreased choice for the large reward. Flesinoxan disrupted task execution by lowering choice for the large reward even at a delay of 0 s. Eltoprazine slightly increased choice for the large reward, but the 5-HT(1B)-antagonist GR127935 had no effect. Administration of D-cycloserine also had no effect on choice behavior. The data suggest the dopamine D(3)-receptor and the 5-HT(1B)-receptor are interesting targets for treating delay aversion impulsivity. These targets were correctly predicted by the positive correlation between delay aversion and aggressive behavior and the intimate links between delay aversion and substance abuse disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208285     DOI: 10.1016/j.pbb.2006.11.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  14 in total

1.  5-HT3 antagonists decrease discounting rate without affecting sensitivity to reward magnitude in the delay discounting task in mice.

Authors:  Marina Mori; Iku Tsutsui-Kimura; Masaru Mimura; Kenji F Tanaka
Journal:  Psychopharmacology (Berl)       Date:  2018-06-28       Impact factor: 4.530

2.  Recent Insights into the Neurobiology of Impulsivity.

Authors:  Marci R Mitchell; Marc N Potenza
Journal:  Curr Addict Rep       Date:  2014-12-01

3.  Genetic and Modeling Approaches Reveal Distinct Components of Impulsive Behavior.

Authors:  Katherine M Nautiyal; Melanie M Wall; Shuai Wang; Valerie M Magalong; Susanne E Ahmari; Peter D Balsam; Carlos Blanco; René Hen
Journal:  Neuropsychopharmacology       Date:  2016-12-15       Impact factor: 7.853

Review 4.  Dissecting drug effects in preclinical models of impulsive choice: emphasis on glutamatergic compounds.

Authors:  Justin R Yates
Journal:  Psychopharmacology (Berl)       Date:  2018-01-06       Impact factor: 4.530

5.  Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy.

Authors:  Valerie Voon; Jeffrey W Dalley
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

6.  Sex differences in response to amphetamine in adult Long-Evans rats performing a delay-discounting task.

Authors:  Paul A Eubig; Terese E Noe; Stan B Floresco; Jeffrey J Sable; Susan L Schantz
Journal:  Pharmacol Biochem Behav       Date:  2013-12-31       Impact factor: 3.533

Review 7.  The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.

Authors:  Catharine A Winstanley
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 8.  Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions.

Authors:  Jennifer L Perry; Jane E Joseph; Yang Jiang; Rick S Zimmerman; Thomas H Kelly; Mahesh Darna; Peter Huettl; Linda P Dwoskin; Michael T Bardo
Journal:  Brain Res Rev       Date:  2010-09-15

9.  Impulsive choice and response in dopamine agonist-related impulse control behaviors.

Authors:  Valerie Voon; Brady Reynolds; Christina Brezing; Cecile Gallea; Meliha Skaljic; Vindhya Ekanayake; Hubert Fernandez; Marc N Potenza; Raymond J Dolan; Mark Hallett
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

10.  Effects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation.

Authors:  Takayuki Tanno; David R Maguire; Cedric Henson; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2013-08-21       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.